secretin gastrointestinal peptides online manufacturer Manufacturer

Secretin (porcine),Catalog Number: KS042008,CAS NO.: 17034-34-3 Secretin, porcine TFA (Porcine secretin TFA) is a 27-amino acid peptide, acting on pancreatic acinar cells and ductal epithelial cells stimulating the production of bicarbonate rich fluid.Secretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.

Secretin (human),Catalog Number: KS042012,CAS NO.: 108153-74-8 Secretin (human) is a gastrointestinal peptide that stimulates pancreatic and biliary secretion. Also thought to play a role in the regulation of the hypothalamus-pituitary-adrenal axis.

Secretin (human),Catalog Number: KS042012,CAS NO.: 108153-74-8 Secretin (human) is a gastrointestinal peptide that stimulates pancreatic and biliary secretion. Also thought to play a role in the regulation of the hypothalamus-pituitary-adrenal axis.

GLP-2 (1-34) (human),CAS#: 99120-49-7, Catalog Number: KS032009 Glucagon-like peptide-2 (GLP-2) promotes nutrient absorption via expansion of the mucosal epithelium by stimulation of crypt cell proliferation and inhibition of apoptosis in the small intestine. It also reduces epithelial permeability, and decreases meal-stimulated gastric acid secretion and gastrointestinal motility. GLP-2 promotes the expansion of the intestinal epithelium through stimulation of the GLP-2

GLP-2 (rat),CAS#: 195262-56-7, Catalog Number: KS031014 Glucagon-like peptide-2 (GLP-2) promotes nutrient absorption via expansion of the mucosal epithelium by stimulation of crypt cell proliferation and inhibition of apoptosis in the small intestine. It also reduces epithelial permeability, and decreases meal-stimulated gastric acid secretion and gastrointestinal motility. GLP-2 promotes the expansion of the intestinal epithelium through stimulation of the GLP-2 receptor, a

GLP-2 (1-34) (human),Catalog Number: KS061029,CAS NO.: 99120-49-7 GLP-2 (Glucagon-like peptide-2) induces the expansion of the mucosal epithelium in the small intestine by stimulating crypt cell proliferation while inhibiting apoptosis. This expansion leads to an increase in nutrient absorption while simultaneously reducing epithelial permeability and decreasing meal-stimulated gastric acid secretion and gastrointestinal motility. GLP-2 achieves these effects by activating